Dataset Information

The interactions between monocarboxylate transporter genes MCT1, MCT2, and MCT4 and the kinetics of blood lactate production and removal after high-intensity efforts in elite males: a cross-sectional study

ABSTRACT: This cross-sectional study investigated the effect of genetic variations in monocarboxylate transporter (MCT) genes on lactate production and removal in 337 male athletes from Poland and the Czech Republic. Participants underwent high-intensity intermittent Wingate tests, with DNA samples collected for SNP analysis. Results showed that the MCT2 TAC haplotype was more prevalent in sprinters, correlating with increased lactate concentration differences and altered lactate clearance. The study highlights potential genetic biomarkers for sprinting performance while emphasizing the need for further research to explore underlying mechanisms and the complex influences on athletic performance.

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: European Variation Archive (EVA)

PROVIDER: PRJEB85239 | EVA | 2025-01-27

REPOSITORIES: EVA

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	MCT_1_2_4.vcf.csi	Other
	MCT_1_2_4.vcf.gz	Vcf
	MCT_1_2_4.vcf.gz.csi	Vcf

Items per page:

1 - 3 of 3

Similar Datasets

Project description:We conducted a small cross-sectional proteomic study aiming to identify potential biomarkers of emphysema, as well as to identify COPD- and smoking-related biomarkers. This study was approved by the University Hospital Dubrava's Institutional Ethics Committee (approval no. 2022/2908‐05), as well as by the School of Medicine, University of Zagreb's Institutional Ethics Committee (approval no. 251-59-10106-24-111/119). This study included a total of 40 participants, divided into four equal age and gender-matched groups (N=10 participants per group): 1.) patients with COPD and radiologically verified emphysema on chest CT (CE group), confirmed by a radiologist, 2.) patients with COPD without radiological signs of emphysema on chest CT (CN group), confirmed by a radiologist, 3) healthy smokers (active smokers (>20 pack-years) without respiratory symptoms and normal spirometry) (HS group), 4) healthy never-smokers (without respiratory symptoms and with normal spirometry) (HN group). A graphic study outline is shown in Figure 1. Participants were included in the study in a non-probabilistic manner (in order to be age, gender, comorbidity and body mass index matched – so group homogeneity in these regards could be achieved). Patients with COPD (CE and CN groups) were GOLD 2B patients as defined by GOLD 2023, active smokers (>20 pack-years), on dual inhalation therapy (combination of long-acting β2 agonist (LABA) and long-acting muscarinic antagonist (LAMA)). Exclusion criteria were: reversible airflow limitation, positive bronchodilator test (either by the GINA criteria or by the ERS/ATS technical standard 2022; acute exacerbation of COPD in the last 6 months, concomitant malignancy, autoimmune disease or concomitant asthma, as well as alpha-1-antitrypsin deficiency. Patients that consumed tobacco products other than classical cigarettes (including e-cigarettes, heat not-burn tobacco products, vape, cigars and cigarillos) were also excluded from the study. None of the participants were taking glucocorticoids or other immunosuppressive medications. All subjects in the study signed an informed consent form. Comorbidities were assessed using the Charlson's comorbidity index and also a modified Charlson's comorbidity index in which “chronic pulmonary disease“ was excluded. The participants underwent spirometry testing and all COPD patients had a chest CT no older than 3 months prior to inclusion. Spirometry with a subsequent bronchodilator test (with 400mcg of salbutamol) was performed according to the international standards, using the Global Lung Initiative (GLI) reference values. Expiratory airflow limitation was determined using the proposed GOLD criteria with a fixed FEV1/FVC ratio of 0.7.

Project description:Elite performing exercise requires an intricate modulation of the blood pressure to support the working muscles with oxygen. We have previously identified a genomic regulatory module that associates with differences in blood pressures of importance for elite performance in racehorses. This study aimed to determine the effect of the regulatory module on the protein repertoire. We sampled plasma from 12 Coldblooded trotters divided into two endothelial regulatory module haplotype groups, a sub-elite performing haplotype (SPH) and an elite performing haplotype (EPH). By sampling each at rest and exercise, we aimed to quantify the regulatory module's effect on blood pressure. The haplotype groups and their interaction were interrogated in two analyses, i) individual paired ratio analysis for identifying differentially abundant proteins of exercise (DAPE) and interaction (DAPI) between haplotype and exercise, and ii) unpaired ratio analysis for identifying differentially abundant protein of haplotype (DAPH). At an expression fold change >1.5, our analyses identified 39 (DAPE), 53 (DAPH) and 20 (DAPI) proteins that showed significantly different expression levels (p-value ≤ 0.05). The proteomics analyses revealed a widespread change in plasma protein content during exercise, regardless of haplotype status, with a decrease tendency in protein abundance that mainly related to lung function, tissue fluids, metabolism, calcium ion pathway and cellular energy metabolism. Furthermore, we provide the first investigation of the proteome variation due to interaction between exercise and related blood pressure haplotypes, which this difference was related to a faster switch to the lipoprotein and lipid metabolism during exercise for EPH. The molecular signatures identified in the present study contribute to improved understanding of the biological mechanisms behind exercise and exercise-related blood pressure regulation of the module that affect racing performance in horses.

Dataset Information

The interactions between monocarboxylate transporter genes MCT1, MCT2, and MCT4 and the kinetics of blood lactate production and removal after high-intensity efforts in elite males: a cross-sectional study

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets